Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adrenocortical carcinoma.

R D Schulick1, M F Brennan

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

World Journal of Urology
|March 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Staging of soft tissue sarcomas.

Annals of surgical oncology·1999
Same author

Pathologic features of prognostic significance for adrenocortical carcinoma after curative resection.

Archives of surgery (Chicago, Ill. : 1960)·1999
Same author

Multifactorial analysis of long-term follow-up (more than 5 years) of primary extremity sarcoma.

Archives of surgery (Chicago, Ill. : 1960)·1999
Same author

Multifactorial analysis of the survival of patients with distant metastasis arising from primary extremity sarcoma.

Cancer·1999
Same author

Growth hormone, alone and in combination with insulin, increases whole body and skeletal muscle protein kinetics in cancer patients after surgery.

Annals of surgery·1999
Same author

Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.

Journal of the National Cancer Institute·1999

Adrenocortical carcinoma is a rare cancer, often diagnosed at advanced stages. Complete surgical resection offers the best chance for long-term survival, though recurrence is common.

Area of Science:

  • Endocrinology
  • Oncology

Background:

  • Adrenocortical carcinoma (ACC) is a rare endocrine malignancy.
  • It predominantly affects women and occurs in the first, fourth, and fifth decades of life.
  • Tumors are classified as functional or nonfunctional based on hormone production.

Purpose of the Study:

  • To summarize the current understanding of adrenocortical carcinoma.
  • To highlight diagnostic and prognostic factors.
  • To review treatment strategies and outcomes.

Main Methods:

  • Review of existing literature on adrenocortical carcinoma.
  • Analysis of diagnostic imaging techniques like CT and MRI.
  • Evaluation of surgical and chemotherapeutic treatment modalities.

Related Experiment Videos

Main Results:

  • Most patients present with large, Stage IV tumors.
  • Complete surgical resection is the only potentially curative treatment.
  • Mitotane is the primary chemotherapy, with limited efficacy but potential benefit from serum level monitoring.

Conclusions:

  • Early stage and complete resection are key prognostic factors for adrenocortical carcinoma.
  • Recurrence and metastasis are frequent, even after curative resection.
  • Reoperation is the primary treatment for recurrent disease.